Lot-to-lot consistency of a hexavalent DTwP-IPV-HB-PRP∼T vaccine and non-inferiority to separate DTwP-HB-PRP∼T and IPV antigen-matching vaccines at 6-8, 10-12, and 14-16 weeks of age co-administered with oral rotavirus vaccine in healthy infants in India: A multi-center, randomized, controlled study
一项多中心、随机、对照研究，旨在评估六价DTwP-IPV-HB-PRP∼T疫苗的批间一致性，以及在印度健康婴儿6-8周、10-12周和14-16周龄时与口服轮状病毒疫苗联合接种的DTwP-HB-PRP∼T疫苗和IPV抗原匹配疫苗的非劣效性。
期刊:Vaccine: X
影响因子:2.2
doi:10.1016/j.jvacx.2022.100216
Mangarule, S; Prashanth, S; Kawade, A; Ravi, M D; Padmavathi, I V; Palkar, S; Tripathi, V N; Singh, R; Maurya, M; Mitra, M; Shetty, R S; Kompithra, R Z; Dhaded, S M; Epari, V; Moureau, A; Jayanth, M V; Varghese, K; Ravinuthala, S; Kukian, D; Patnaik, B N; Noriega, F
